Tags | Domains | Searches | Statistics | Options | Advanced Search
|
Tags | Domains | Searches | Statistics | Options | Advanced Search |
PharmaGazette - Jun 30, 2008
GlaxoSmithKline (NYSE: GSK ) announced that it has submitted its response to the U.S. Food and Drug Administration to questions the agency had in response to GSK's drug application for Cervarix. Cervarix, a vaccine …
Also tagged: fda, r, cervical cancer, drug regulations and approval, cervarix
Know More Media - Health Care / Pharmaceutical / Fitness - Jun 30, 2008
GlaxoSmithKline (NYSE: GSK ) announced that it has submitted its response to the U.S. Food and Drug Administration to questions the agency had in response to GSK's drug application for Cervarix. Cervarix, a vaccine …
Also tagged: fda, r, cervical cancer, drug regulations and approval, cervarix
PharmaGazette - Jun 30, 2008
Company Name, Symbol, Share Price, Change Abbott Laboratories' (NYSE: ABT ) - $52.97 -0.03 (-0.06%) AstraZeneca (NYSE: AZN ) - $42.53 +0.78 (+1.87%) Bristol-Myers Squibb (NYSE: BMY ) - $20.53 +0.23 (+1.13%) Eli …
Know More Media - Health Care / Pharmaceutical / Fitness - Jun 30, 2008
Company Name, Symbol, Share Price, Change Abbott Laboratories' (NYSE: ABT ) - $52.97 -0.03 (-0.06%) AstraZeneca (NYSE: AZN ) - $42.53 +0.78 (+1.87%) Bristol-Myers Squibb (NYSE: BMY ) - $20.53 +0.23 (+1.13%) Eli …
PharmaGazette - Jun 25, 2008
The U.S. Food and Drug Administration has approved GlaxoSmithKline's combination booster vaccine, Kinrix. Kinrix protects children between 4 and 6 years old against diphtheria, pertussis, polio and tetanus and is …
Also tagged: fda, drug regulations and approval, infanrix, kinrix, pediarix
Know More Media - Health Care / Pharmaceutical / Fitness - Jun 25, 2008
The U.S. Food and Drug Administration has approved GlaxoSmithKline's combination booster vaccine, Kinrix. Kinrix protects children between 4 and 6 years old against diphtheria, pertussis, polio and tetanus and is …
Also tagged: fda, drug regulations and approval, infanrix, kinrix, pediarix
Know More Media - Health Care / Pharmaceutical / Fitness - Jun 25, 2008
The U.S. Department of Justice confirmed that its investigation into whether GlaxoSmithKline withheld data concerning adverse risk associated with Paxil has been expanded to include the U.S. attorney's office in Boston …
Also tagged: news, lawsuit, suicide, paxil, fda warning
PharmaGazette - Jun 25, 2008
The U.S. Department of Justice confirmed that its investigation into whether GlaxoSmithKline withheld data concerning adverse risk associated with Paxil has been expanded to include the U.S. attorney's office in Boston …
Also tagged: news, lawsuit, suicide, paxil, fda warning
Know More Media - Health Care / Pharmaceutical / Fitness - Jun 24, 2008
The U.S. Food and Drug Administration has approved GlaxoSmithKline (NYSE: GSK ) Avodart in combination with tamsulosin for the treatment of symptomatic enlarged prostate. Enlarged prostate is a disease that affects …
Also tagged: aur, drug regulations and approval, avodart, enlarged prostate
PharmaGazette - Jun 24, 2008
The U.S. Food and Drug Administration has approved GlaxoSmithKline (NYSE: GSK ) Avodart in combination with tamsulosin for the treatment of symptomatic enlarged prostate. Enlarged prostate is a disease that affects …
Also tagged: aur, drug regulations and approval, avodart, enlarged prostate